Axogen Deferred Long Term Liab vs Retained Earnings Analysis
AXGN Stock | USD 12.47 0.07 0.56% |
Axogen financial indicator trend analysis is way more than just evaluating Axogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axogen Inc is a good investment. Please check the relationship between Axogen Deferred Long Term Liab and its Retained Earnings accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Deferred Long Term Liab vs Retained Earnings
Deferred Long Term Liab vs Retained Earnings Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axogen Inc Deferred Long Term Liab account and Retained Earnings. At this time, the significance of the direction appears to have pay attention.
The correlation between Axogen's Deferred Long Term Liab and Retained Earnings is -0.92. Overlapping area represents the amount of variation of Deferred Long Term Liab that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Axogen Inc, assuming nothing else is changed. The correlation between historical values of Axogen's Deferred Long Term Liab and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Deferred Long Term Liab of Axogen Inc are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Deferred Long Term Liab i.e., Axogen's Deferred Long Term Liab and Retained Earnings go up and down completely randomly.
Correlation Coefficient | -0.92 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Deferred Long Term Liab
Liabilities that are due after more than one year, including deferred tax liabilities and deferred revenue.Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Most indicators from Axogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. At this time, Axogen's Selling General Administrative is very stable compared to the past year. As of the 15th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.36, though Enterprise Value Over EBITDA is likely to grow to (23.17).
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 1.4M | 624K | 2.8M | 1.6M | Depreciation And Amortization | 4.7M | 4.9M | 5.6M | 5.8M |
Axogen fundamental ratios Correlations
Click cells to compare fundamentals
Axogen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Axogen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 154.6M | 201.4M | 208.0M | 195.4M | 196.8M | 206.7M | |
Short Long Term Debt Total | 3.3M | 53.8M | 67.5M | 67.4M | 69.3M | 72.8M | |
Other Current Liab | 10.9M | 16.5M | 16.5M | 13.5M | 17.1M | 18.0M | |
Total Current Liabilities | 20.9M | 22.8M | 24.3M | 23.8M | 30.4M | 32.0M | |
Total Stockholder Equity | 132.2M | 123.1M | 112.6M | 101.0M | 95.7M | 100.4M | |
Property Plant And Equipment Net | 18.1M | 54.1M | 78.1M | 93.7M | 104.3M | 109.5M | |
Net Debt | (32.4M) | 5.0M | 34.7M | 52.1M | 32.3M | 33.9M | |
Retained Earnings | (179.9M) | (203.6M) | (230.6M) | (259.6M) | (281.3M) | (267.2M) | |
Cash | 35.7M | 48.8M | 32.8M | 15.3M | 37.0M | 38.9M | |
Non Current Assets Total | 19.6M | 56.1M | 81.0M | 97.3M | 108.8M | 114.3M | |
Non Currrent Assets Other | (19.6M) | 15.7M | (81.0M) | (97.3M) | (87.6M) | (83.2M) | |
Cash And Short Term Investments | 96.5M | 104.0M | 84.1M | 48.8M | 37.0M | 20.0M | |
Net Receivables | 16.9M | 17.6M | 18.2M | 22.2M | 25.1M | 26.4M | |
Common Stock Shares Outstanding | 39.2M | 40.0M | 41.2M | 42.1M | 42.9M | 45.0M | |
Liabilities And Stockholders Equity | 154.6M | 201.4M | 208.0M | 195.4M | 196.8M | 206.7M | |
Non Current Liabilities Total | 1.6M | 55.4M | 71.2M | 70.6M | 70.7M | 74.3M | |
Inventory | 13.9M | 12.5M | 16.7M | 18.9M | 23.0M | 24.2M | |
Other Stockholder Equity | 311.6M | 326.4M | 342.8M | 360.2M | 376.5M | 395.4M | |
Total Liab | 22.5M | 78.2M | 95.5M | 94.4M | 101.2M | 106.2M | |
Property Plant And Equipment Gross | 18.1M | 54.1M | 85.7M | 93.7M | 118.0M | 123.9M | |
Total Current Assets | 135.0M | 145.3M | 127.0M | 98.1M | 88.0M | 92.4M | |
Short Term Debt | 1.7M | 1.7M | 1.8M | 1.3M | 1.5M | 1.5M | |
Intangible Assets | 1.5M | 2.1M | 2.9M | 3.6M | 4.5M | 4.8M | |
Other Current Assets | 1.7M | 11.1M | 8.1M | 8.2M | 8.8M | 9.3M | |
Accounts Payable | 8.3M | 4.6M | 5.9M | 9.0M | 11.8M | 12.4M | |
Common Stock Total Equity | 396K | 406K | 417K | 424K | 487.6K | 512.0K | |
Common Stock | 396K | 406K | 417K | 424K | 431K | 452.6K | |
Other Liab | 164K | 112K | 15K | 3K | 2.7K | 2.6K | |
Property Plant Equipment | 18.1M | 38.4M | 78.1M | 93.7M | 107.7M | 113.1M | |
Net Tangible Assets | 130.6M | 121.1M | 109.7M | 97.4M | 112.0M | 58.6M | |
Long Term Debt | 1.6M | 52.9M | 65.6M | 66.1M | 46.6M | 33.6M | |
Long Term Debt Total | 30K | 52.9M | 65.6M | 66.1M | 76.0M | 79.8M | |
Capital Surpluse | 311.6M | 326.4M | 342.8M | 360.2M | 414.2M | 210.4M | |
Short Long Term Debt | 4.7M | 28K | 1.7M | 863K | 776.7K | 737.9K |
Pair Trading with Axogen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.Moving against Axogen Stock
0.52 | GH | Guardant Health | PairCorr |
0.49 | DXCM | DexCom Inc | PairCorr |
0.41 | SNDA | Sonida Senior Living | PairCorr |
0.39 | AGL | agilon health | PairCorr |
0.37 | MBOT | Microbot Medical | PairCorr |
The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.
The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.33) | Revenue Per Share 4.16 | Quarterly Revenue Growth 0.179 | Return On Assets (0.03) | Return On Equity (0.15) |
The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.